Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marshall Posner

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
AIDS Research and Human Retroviruses|October 18, 2005
Human single-chain antibodies inhibit replication of human immunodeficiency virus type 1 (HIV-1)Fangbing Liu, Mukesh Kumar, Qiangzhong Ma, et al.
Anticancer Research|March 2, 2018
Surveillance Imaging in HPV-related Oropharyngeal CancerWilliam Su, Brett A Miles, Marshall Posner, et al.
Head & Neck|April 23, 2015
Endothelial growth factor receptor inhibitors in recurrent metastatic cancer of the head and neckKrzysztof Misiukiewicz, Rajan P Dang, Michael Parides, et al.
Cancer Reports (Hoboken, N.J.)|March 21, 2026
Development of Glioblastoma Multiforme in Patients With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma: A Case SeriesJessica T Lovett, Michael Wotman, Ryan Denu, et al.
Oral Oncology|April 1, 2014
Does response to induction chemotherapy (IC) predict locoregional control after concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC)?Ryan Cotter, Seth Blacksburg, Todd Carpenter, et al.
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neckKrzysztof Misiukiewicz, Nadia Camille, Vishal Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the OropharynxKristina R Dahlstrom, Karen S Anderson, Julia N Cheng, et al.
Oral Oncology|June 4, 2013
A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)Sewanti Limaye, Sarah Riley, Sihai Zhao, et al.
Archives of Otolaryngology--Head & Neck Surgery|June 21, 2006
Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neckRobert Haddad, Roy Tishler, Lori Wirth, et al.
Oral Oncology|August 20, 2025
Predictive value of circulating tumor tissue-modified HPV DNA kinetics in induction therapy for oropharyngeal squamous cell carcinomaMegan Tang, Max Dougherty, Leslie Worona, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
AIDS Research and Human Retroviruses|October 18, 2005
Human single-chain antibodies inhibit replication of human immunodeficiency virus type 1 (HIV-1)Fangbing Liu, Mukesh Kumar, Qiangzhong Ma, et al.
Anticancer Research|March 2, 2018
Surveillance Imaging in HPV-related Oropharyngeal CancerWilliam Su, Brett A Miles, Marshall Posner, et al.
Head & Neck|April 23, 2015
Endothelial growth factor receptor inhibitors in recurrent metastatic cancer of the head and neckKrzysztof Misiukiewicz, Rajan P Dang, Michael Parides, et al.
Cancer Reports (Hoboken, N.J.)|March 21, 2026
Development of Glioblastoma Multiforme in Patients With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma: A Case SeriesJessica T Lovett, Michael Wotman, Ryan Denu, et al.
Oral Oncology|April 1, 2014
Does response to induction chemotherapy (IC) predict locoregional control after concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC)?Ryan Cotter, Seth Blacksburg, Todd Carpenter, et al.
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neckKrzysztof Misiukiewicz, Nadia Camille, Vishal Gupta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the OropharynxKristina R Dahlstrom, Karen S Anderson, Julia N Cheng, et al.
Oral Oncology|June 4, 2013
A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)Sewanti Limaye, Sarah Riley, Sihai Zhao, et al.
Archives of Otolaryngology--Head & Neck Surgery|June 21, 2006
Rate of pathologic complete responses to docetaxel, cisplatin, and fluorouracil induction chemotherapy in patients with squamous cell carcinoma of the head and neckRobert Haddad, Roy Tishler, Lori Wirth, et al.
Oral Oncology|August 20, 2025
Predictive value of circulating tumor tissue-modified HPV DNA kinetics in induction therapy for oropharyngeal squamous cell carcinomaMegan Tang, Max Dougherty, Leslie Worona, et al.
Pageof 10